| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Ali Asif is a Chief Financial Officer at Protagonist Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $7.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 26, 2026 | PTGX Protagonist Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 24,765 | $104.24 | $2,581,503.60 | -29.0% | - | - | |
| Apr 22, 2025 | PTGX Protagonist Therapeutics, Inc | Chief Financial Officer | Sell | 1,756 | $46.00 | $80,776.00 | -2.8% | +20.4% | - | |
| Mar 12, 2025 | PTGX Protagonist Therapeutics, Inc | Chief Financial Officer | Sale+OE | 24,903 | $58.73 | $1,462,553.19 | -28.4% | -2.2% | +65.5% | |
| Jan 16, 2025 | PTGX Protagonist Therapeutics, Inc | Chief Financial Officer | Sell | 3,918 | $0.00 | - | -3.0% | +25.3% | +124.4% | |
| Sep 11, 2024 | PTGX Protagonist Therapeutics, Inc | Chief Financial Officer | Sale+OE | 14,203 | $44.49 | $631,871.77 | -16.9% | -7.1% | +33.2% | |
| Apr 18, 2024 | PTGX Protagonist Therapeutics, Inc | Chief Financial Officer | Sell | 1,234 | $25.11 | $30,985.74 | -3.2% | +42.4% | +83.5% | |
| Mar 1, 2024 | PTGX Protagonist Therapeutics, Inc | Chief Financial Officer | Sale+OE | 24,187 | $31.60 | $764,365.34 | -13.0% | -13.8% | +16.9% |